Hot Pursuit     02-Jul-24
IOL Chem soars on China approval for cholesterol drug
IOL Chemicals & Pharmaceuticals surged 7.76% to Rs 441.05 after China's National Medical Products Administration (NMPA) approved the company's Fenofibrate drug.
The NMPA's green light paves the way for IOL Chemicals to export its Fenofibrate to the Chinese market. The drug is used to treat high cholesterol and triglyceride levels in the blood.

IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer. Its consolidated net profit declined 57.36% to Rs 27.62 crore on 14.18% fall in net sales to Rs 503.92 crore in Q4 March 2024 over Q4 March 2023.

Previous News
  IOL Chem soars on China approval for cholesterol drug
 ( Hot Pursuit - 02-Jul-24   10:24 )
  IOL Chemicals & Pharmaceuticals to convene AGM
 ( Corporate News - 15-May-24   16:28 )
  IOL Chemicals & Pharmaceuticals consolidated net profit declines 57.36% in the March 2024 quarter
 ( Results - Announcements 14-May-24   18:47 )
  IOL Chemicals & Pharmaceuticals to table results
 ( Corporate News - 07-May-24   11:48 )
  IOL Chemicals & Pharmaceuticals Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Mar-24   12:00 )
  Indices turn rangebound; FMCG shares declines for 2nd day
 ( Market Commentary - Mid-Session 19-Mar-24   11:32 )
  IOL Chemical spurts after receiving zero observations from ANVISA for 10 manufacturing units
 ( Hot Pursuit - 19-Mar-24   11:14 )
  IOL Chemicals to commence export of Metformin Hydrochloride in China
 ( Corporate News - 19-Feb-24   12:42 )
  Board of IOL Chemicals & Pharmaceuticals recommends interim dividend
 ( Corporate News - 07-Feb-24   11:34 )
  IOL Chemicals & Pharmaceuticals schedules board meeting
 ( Corporate News - 30-Jan-24   15:37 )
  IOL Chemicals & Pharmaceuticals consolidated net profit rises 138.03% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   07:55 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top